Qiming Venture Partners

Qiming Venture Partners is a leading global venture capital firm managing multiple US Dollar and RMB funds with over $9.5 billion in capital raised. They focus on early and growth-stage investments in Technology & Consumer and Healthcare sectors, boasting a portfolio of influential companies.

Founded 2006 · Venture Capital

Shanghai (China), Beijing (China), Hong Kong ([object Object]), Suzhou (China), Singapore ([object Object])

Investment Stages

Series A

Series B

Markets

Healthcare

Life Sciences

Biotechnology

Artificial Intelligence

SaaS

Consumer

Fintech

Portfolio Companies

Xiaomi, Meituan, Bilibili, Zhihu, Roborock, UBTech, WeRide, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, Yuanxin Technology, Caidya, Belief BioMed, HyperStrong, WeDoctor, Dianping, Tigermed, ZaiLab, UBTech, Berry Genomics, CooTek, Sinocelltech, Tongdun, Tellgen, Unisound, Cansinotech, Mafengwo, Meitu, Bilibili, Roborock, Miaoshou Doctor, Transwarp, Tujia

Links

Website Team Page Portfolio LinkedIn X Crunchbase PitchBook

Related VC firms in China

6 Dimensions Capital

Life Sciences, Healthcare

Aera VC

Climate Tech, Frontier, Deep tech, Sustainability

ATM Capital

E-commerce, Logistics, Consumer Retail, Fintech, Renewable Energy

Share this page

Want more backlinks, traffic, and startup visibility?

Get your startup listed in 100+ directories automatically. Perfect for SaaS, AI, and tech startups.

Submit Your Startup